These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19569080)

  • 21. Genetic variants of PPAR-gamma coactivator 1B augment NLRP3-mediated inflammation in gouty arthritis.
    Chang WC; Jan Wu YJ; Chung WH; Lee YS; Chin SW; Chen TJ; Chang YS; Chen DY; Hung SI
    Rheumatology (Oxford); 2017 Mar; 56(3):457-466. PubMed ID: 28394398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pigment epithelium-derived factor induces interleukin-10 expression in human macrophages by induction of PPAR gamma.
    Yang SL; Chen SL; Wu JY; Ho TC; Tsao YP
    Life Sci; 2010 Jul; 87(1-2):26-35. PubMed ID: 20553736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in gelatinases expression and activity in human atria during atrial fibrillation].
    Ke D; Xu CX; Zhang JC; Chen L; Lin YZ; Lin LF; Hu XZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb; 33(2):137-42. PubMed ID: 15924808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pilot study of circulating PPAR-γ receptor protein in elderly patients with atrial fibrillation.
    Lin Q; Jia L; Sun Y
    Arch Med Sci; 2012 Jul; 8(3):471-6. PubMed ID: 22852002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased Expression of T Cell Immunoglobulin and Mucin Domain 3 on CD14
    Xu C; Ge H; Wang T; Qin J; Liu D; Liu Y
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1226-1236. PubMed ID: 29310959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pentraxin 3 is a local inflammatory marker in atrial fibrillation.
    Soeki T; Bando S; Uematsu E; Matsuura T; Niki T; Ise T; Kusunose K; Hotchi J; Ueda Y; Tomita N; Yamaguchi K; Yagi S; Fukuda D; Taketani Y; Iwase T; Yamada H; Wakatsuki T; Shimabukuro M; Sata M
    Heart Vessels; 2014 Sep; 29(5):653-8. PubMed ID: 23979265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KLF5 overexpression attenuates cardiomyocyte inflammation induced by oxygen-glucose deprivation/reperfusion through the PPARγ/PGC-1α/TNF-α signaling pathway.
    Li Y; Li J; Hou Z; Yu Y; Yu B
    Biomed Pharmacother; 2016 Dec; 84():940-946. PubMed ID: 27764756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of ghrelin on left ventricular remodeling in spontaneously hypertensive rats is associated with the peroxisome proliferator-activated receptor gamma-dependent pathway.
    Li Z; Zhu XY; Li M; Bai YL; Hu J
    Chin Med J (Engl); 2008 Nov; 121(22):2299-304. PubMed ID: 19080336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of the peroxisome proliferator-activated receptor gamma in the immune system of weaned pigs after Escherichia coli lipopolysaccharide injection.
    Liu Y; Lu J; Shi J; Hou Y; Zhu H; Zhao S; Liu H; Ding B; Yin Y; Yi G
    Vet Immunol Immunopathol; 2008 Jul; 124(1-2):82-92. PubMed ID: 18394717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulated atrial gene expression of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand axis in the development and progression of atrial fibrillation.
    Cao H; Wang J; Xi L; Røe OD; Chen Y; Wang D
    Circ J; 2011; 75(12):2781-8. PubMed ID: 22001292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of tumor necrosis factor-alpha-induced interleukin-6 expression by telmisartan through cross-talk of peroxisome proliferator-activated receptor-gamma with nuclear factor kappaB and CCAAT/enhancer-binding protein-beta.
    Tian Q; Miyazaki R; Ichiki T; Imayama I; Inanaga K; Ohtsubo H; Yano K; Takeda K; Sunagawa K
    Hypertension; 2009 May; 53(5):798-804. PubMed ID: 19289654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation.
    Zhao F; Zhang S; Shao Y; Wu Y; Qin J; Chen Y; Chen L; Gu H; Wang X; Huang C; Zhang W
    Int J Cardiol; 2013 Oct; 168(3):2177-85. PubMed ID: 23465222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced glycation end products downregulates peroxisome proliferator-activated receptor γ expression in cultured rabbit chondrocyte through MAPK pathway.
    Yang Q; Chen C; Wu S; Zhang Y; Mao X; Wang W
    Eur J Pharmacol; 2010 Dec; 649(1-3):108-14. PubMed ID: 20863825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eicosapentaenoic acid inhibits interleukin-6 production in interleukin-1beta-stimulated C6 glioma cells through peroxisome proliferator-activated receptor-gamma.
    Kawashima A; Harada T; Imada K; Yano T; Mizuguchi K
    Prostaglandins Leukot Essent Fatty Acids; 2008; 79(1-2):59-65. PubMed ID: 18762411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uric acid levels and atrial fibrillation in hypertensive patients.
    Liu T; Zhang X; Korantzopoulos P; Wang S; Li G
    Intern Med; 2011; 50(8):799-803. PubMed ID: 21498925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective assessment of cytokine IL-15 activity in patients with refractory atrial fibrillation episodes.
    Borowiec A; Kontny E; Smolis-Bąk E; Kowalik I; Majos E; Załucka L; Plaziński K; Maśliński W; Szwed H; Dabrowski R
    Cytokine; 2015 Jul; 74(1):164-70. PubMed ID: 25936571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating intermediate CD14++CD16+monocytes are increased in patients with atrial fibrillation and reflect the functional remodelling of the left atrium.
    Suzuki A; Fukuzawa K; Yamashita T; Yoshida A; Sasaki N; Emoto T; Takei A; Fujiwara R; Nakanishi T; Yamashita S; Matsumoto A; Konishi H; Ichibori H; Hirata KI
    Europace; 2017 Jan; 19(1):40-47. PubMed ID: 26826137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agonist of peroxisome proliferator-activated receptor gamma (PPAR-gamma): a new compound with potent gastroprotective and ulcer healing properties.
    Brzozowski T; Konturek PC; Pajdo R; Kwiecień SN; Konturek S; Targosz A; Burnat G; Cieszkowski J; Pawlik WW; Hahn EG
    Inflammopharmacology; 2005; 13(1-3):317-30. PubMed ID: 16259750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertension and paroxysmal atrial fibrillation: a novel predictive role of high sensitivity C-reactive protein in cardioversion and long-term recurrence.
    Rizos I; Rigopoulos AG; Kalogeropoulos AS; Tsiodras S; Dragomanovits S; Sakadakis EA; Faviou E; Kremastinos DT
    J Hum Hypertens; 2010 Jul; 24(7):447-57. PubMed ID: 20072146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of inflammation and oxidative stress in atrial fibrillation.
    Li J; Solus J; Chen Q; Rho YH; Milne G; Stein CM; Darbar D
    Heart Rhythm; 2010 Apr; 7(4):438-44. PubMed ID: 20153266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.